血管扩张药治疗肺动脉高压的评价  

A Review of Vasodilators in the Treatment of Pulmonary Hypertension

作　　者：王虹[1] 解卫平[1] 杨玉[1] 

机构地区：[1]南京医科大学第一附属医院呼吸内科,南京210029

出　　处：《医药导报》2001年第1期26-27,共2页Herald of Medicine

摘　　要：肺原性心脏病是临床常见病 ,尽管目前治疗手段较多 ,但疗效并不理想 ,预后较差。血管扩张药是近年来研究较多、发展较快的一类治疗肺动脉高压药物。对近 5年来血管扩张药治疗肺动脉高压的研究进展进行了综述 ;Cor pulmonale is a common disease. The intervention varies and the effectiveness remains unsatisfactory. The vasodilators have been studied intensively in recent years and their application in treating the disease has been developing quickly. In this paper, the advances of research on the vasodilators in treatment of pulmonary hypertension in the last 5 years is reviewed, the advantages and disadvantages of the drugs presented, and a discussion on the trend of treatment of pulmonary hypertension made.

关 键 词：血管扩张药 肺动脉高压 疗效 药物疗法 

分 类 号：R543.205[医药卫生—心血管疾病]